27312379|t|Evaluation of the in vitro growth of urinary tract infection -causing gram-negative and gram-positive bacteria in a proposed synthetic human urine (SHU) medium
27312379|a|Bacteriuria is a hallmark of urinary tract infection (UTI) and asymptomatic bacteriuria (ABU), which are among the most frequent infections in humans. A variety of gram-negative and gram-positive bacteria are associated with these infections but Escherichia coli contributes up to 80% of cases. Multiple bacterial species including E. coli can grow in human urine as a means to maintain colonization during infections. In vitro bacteriuria studies aimed at modeling microbial growth in urine have utilized various compositions of synthetic human urine (SHU) and a Composite SHU formulation was recently proposed. In this study, we sought to validate the recently proposed Composite SHU as a medium that supports the growth of several bacterial species that are known to grow in normal human urine and/or artificial urine. Comparative growth assays of gram-negative and gram-positive bacteria E. coli, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus agalactiae, Staphylococcus saprophyticus and Enterococcus faecalis were undertaken using viable bacterial count and optical density measurements over a 48h culture period. Three different SHU formulations were tested in various culture vessels, shaking conditions and volumes and showed that Composite SHU can support the robust growth of gram-negative bacteria but requires supplementation with 0.2% yeast extract to support the growth of gram-positive bacteria. Experiments are also presented that show an unexpected but major influence of P. mirabilis towards the ability to measure bacterial growth in generally accepted multiwell assays using absorbance readings, predicted to have a basis in the release of volatile organic compound(s) from P. mirabilis during growth in Composite SHU medium. This study represents an essential methodological validation of a more chemically defined type of synthetic urine that can be applied to study mechanisms of bacteriuria and we conclude will offer a useful in vitro model to investigate the basis of some of the most common infections of humans.
27312379	0	10	Evaluation	T058	UMLS:C0220825
27312379	37	60	urinary tract infection	T038	UMLS:C0042029
27312379	70	83	gram-negative	T007	UMLS:C0018150
27312379	88	110	gram-positive bacteria	T007	UMLS:C0018154
27312379	135	140	human	T204	UMLS:C0086418
27312379	141	146	urine	T031	UMLS:C1610733
27312379	148	151	SHU	T031	UMLS:C1610733
27312379	153	159	medium	T103	UMLS:C0010454
27312379	160	171	Bacteriuria	T038	UMLS:C0004659
27312379	189	212	urinary tract infection	T038	UMLS:C0042029
27312379	214	217	UTI	T038	UMLS:C0042029
27312379	223	247	asymptomatic bacteriuria	T038	UMLS:C0262380
27312379	249	252	ABU	T038	UMLS:C0262380
27312379	289	299	infections	T038	UMLS:C3714514
27312379	303	309	humans	T204	UMLS:C0086418
27312379	324	337	gram-negative	T007	UMLS:C0018150
27312379	342	364	gram-positive bacteria	T007	UMLS:C0018154
27312379	391	401	infections	T038	UMLS:C3714514
27312379	406	422	Escherichia coli	T007	UMLS:C0014834
27312379	464	481	bacterial species	T007	UMLS:C0004611
27312379	492	499	E. coli	T007	UMLS:C0014834
27312379	512	517	human	T204	UMLS:C0086418
27312379	518	523	urine	T031	UMLS:C1610733
27312379	547	559	colonization	T033	UMLS:C4289767
27312379	567	577	infections	T038	UMLS:C3714514
27312379	588	599	bacteriuria	T038	UMLS:C0004659
27312379	600	607	studies	T062	UMLS:C2603343
27312379	617	625	modeling	T062	UMLS:C0870071
27312379	646	651	urine	T031	UMLS:C1610733
27312379	674	686	compositions	T201	UMLS:C0486616
27312379	700	705	human	T204	UMLS:C0086418
27312379	706	711	urine	T031	UMLS:C1610733
27312379	713	716	SHU	T031	UMLS:C1610733
27312379	734	737	SHU	T031	UMLS:C1610733
27312379	781	786	study	T062	UMLS:C2603343
27312379	801	809	validate	T062	UMLS:C1519941
27312379	842	845	SHU	T031	UMLS:C1610733
27312379	851	857	medium	T103	UMLS:C0010454
27312379	894	911	bacterial species	T007	UMLS:C0004611
27312379	945	950	human	T204	UMLS:C0086418
27312379	951	956	urine	T031	UMLS:C1610733
27312379	975	980	urine	T031	UMLS:C1610733
27312379	994	1007	growth assays	T033	UMLS:C0427944
27312379	1011	1024	gram-negative	T007	UMLS:C0018150
27312379	1029	1051	gram-positive bacteria	T007	UMLS:C0018154
27312379	1052	1059	E. coli	T007	UMLS:C0014834
27312379	1061	1083	Pseudomonas aeruginosa	T007	UMLS:C0033809
27312379	1085	1102	Proteus mirabilis	T007	UMLS:C0033701
27312379	1104	1128	Streptococcus agalactiae	T007	UMLS:C0579233
27312379	1130	1158	Staphylococcus saprophyticus	T007	UMLS:C0318112
27312379	1163	1184	Enterococcus faecalis	T007	UMLS:C0038404
27312379	1214	1229	bacterial count	T058	UMLS:C0004618
27312379	1234	1262	optical density measurements	T058	UMLS:C1266211
27312379	1274	1281	culture	T058	UMLS:C0430400
27312379	1306	1309	SHU	T031	UMLS:C1610733
27312379	1420	1423	SHU	T031	UMLS:C1610733
27312379	1457	1479	gram-negative bacteria	T007	UMLS:C0018150
27312379	1519	1532	yeast extract	T204	UMLS:C1960916
27312379	1558	1580	gram-positive bacteria	T007	UMLS:C0018154
27312379	1582	1593	Experiments	T062	UMLS:C0681814
27312379	1626	1636	unexpected	T170	UMLS:C4055646
27312379	1660	1672	P. mirabilis	T007	UMLS:C0033701
27312379	1696	1720	measure bacterial growth	T033	UMLS:C0427944
27312379	1743	1759	multiwell assays	T058	UMLS:C1510438
27312379	1766	1785	absorbance readings	T201	UMLS:C1268822
27312379	1831	1859	volatile organic compound(s)	T103	UMLS:C2350439
27312379	1865	1877	P. mirabilis	T007	UMLS:C0033701
27312379	1905	1908	SHU	T031	UMLS:C1610733
27312379	1909	1915	medium	T103	UMLS:C0010454
27312379	1922	1927	study	T062	UMLS:C2603343
27312379	1952	1966	methodological	T170	UMLS:C0969625
27312379	1967	1977	validation	T062	UMLS:C1519941
27312379	1988	1998	chemically	T103	UMLS:C0220806
27312379	2025	2030	urine	T031	UMLS:C1610733
27312379	2054	2059	study	T062	UMLS:C2603343
27312379	2074	2085	bacteriuria	T038	UMLS:C0004659
27312379	2189	2199	infections	T038	UMLS:C3714514
27312379	2203	2209	humans	T204	UMLS:C0086418